K. Warner

Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patients.

M. Thibonnier, M. Smith, M. Rahman, 1999, Hypertension.

Discovery of a novel small molecule agonist scaffold for the APJ receptor.

K. Bortoff, James B. Thomas, S. Runyon, 2016, Bioorganic & medicinal chemistry.

Identification of N-[(5-{[(4-Methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a Neurotensin-like Nonpeptide Compound Selective for the Neurotensin Receptor Type 2

L. Gendron, James B. Thomas, S. Runyon, 2014, Journal of medicinal chemistry.

The amide linker in nonpeptide neurotensin receptor ligands plays a key role in calcium signaling at the neurotensin receptor type 2.

James B. Thomas, S. Runyon, R. Wiethe, 2015, Bioorganic & medicinal chemistry letters.

Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2.

James B. Thomas, S. Runyon, R. Wiethe, 2015, Bioorganic & medicinal chemistry letters.

Identification of 1-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane Carboxylic Acid as a Selective Nonpeptide Neurotensin Receptor Type 2 Compound

L. Gendron, James B. Thomas, S. Runyon, 2014, Journal of medicinal chemistry.

A Rapid Membrane Potential Assay to Monitor CFTR Function and Inhibition

P. Sivashanmugam, R. Maitra, K. Warner, 2013, Journal of biomolecular screening.

The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay.

James B. Thomas, H. Navarro, B. Gilmour, 2009, Bioorganic & medicinal chemistry letters.